Loading blog post…
A complete guide to polynucleotide (PN) and PDRN skin treatments — how they work, what Jalupro, Rejuran, and Nucleofill do, clinical evidence, and how they differ from hyaluronic acid skin boosters.
· By MedSpot Editorial · 6 min read
Polynucleotides (PN) and polydeoxyribonucleotide (PDRN) treatments are among the fastest-growing segments of aesthetic medicine — and among the least understood by patients who encounter the marketing. Here's what the science actually shows.
Polynucleotides are chains of nucleotides — the building blocks of DNA and RNA. In aesthetic medicine, they're derived from salmon or trout sperm DNA, which has a high degree of homology with human DNA (similarity in base pair sequence). After extraction and purification, the DNA is fragmented into chains of varying lengths.
Two related terms:
In practice, many products are marketed interchangeably; the distinction matters more in clinical research than in typical aesthetic use.
Polynucleotides work through two primary pathways:
1. Receptor-mediated signaling (A2A receptor agonism): PN fragments activate adenosine A2A receptors, which:
2. Nucleotide salvage pathway: The degraded PN fragments are taken up by cells and used as building blocks for new DNA synthesis — directly supporting cell proliferation and tissue regeneration.
Key difference from HA: Hyaluronic acid skin boosters (Profhilo, Restylane Skinboosters, Belotero Revive) work primarily by adding hydration, attracting water to the dermis, and providing a mild physical scaffold. PN treatments work primarily through biological signaling — they stimulate the tissue to regenerate, rather than adding a molecule that provides hydration directly.
The most evidence-supported applications:
Skin quality and texture: Multiple controlled trials show improvement in skin elasticity, smoothness, and hydration over a 3–4 session protocol. The effect accumulates over 8–12 weeks.
Fine lines: Particularly periorbital (around the eyes) and thin-skin areas. The skin regeneration mechanism is well-suited to delicate areas where more aggressive treatments carry higher risk.
Skin laxity (mild): Fibroblast stimulation and collagen synthesis improve skin firmness over time. Not a substitute for structural treatment of significant laxity.
Post-acne skin quality: The anti-inflammatory and collagen-stimulating properties make PN relevant for post-acne skin that has texture irregularities, enlarged pores, and mild scarring.
Post-procedure skin recovery: Some protocols use PN after laser or microneedling to support the healing response and amplify collagen stimulation.
Under-eye area (Rejuran I): One of the specific formulations designed for periorbital skin thinning, crepiness, and fine lines under the eye — an area where many other treatments are too risky or too aggressive.
The evidence base is growing but has limitations:
Strongest evidence: Korean trials on Rejuran with objective skin parameter measurements (Cutometer, Tewameter, Visioface) showing improvements in elasticity, hydration, and smoothness. Generally small sample sizes (20–60 patients) but consistent positive findings.
Honest assessment: The evidence is positive and consistent enough to make PN treatments a credible option — but the evidence base is not as extensive or rigorously powered as, say, the PREEMPT trials for Botox or the major HA filler trials. Most studies are single-arm or small RCTs; long-term durability data beyond 6 months is limited.
Comparison to HA boosters: Head-to-head data is limited. In practice, PN and HA boosters are often used together for complementary effects: PN for biological regeneration, HA for immediate hydration boost.
Standard course: 3–4 sessions, 2–4 weeks apart
Technique: Superficial intradermal injection (skin-whealing technique) — very small volumes distributed across the treatment area using multiple microinjection points. No deep injection needed; the target is the dermis.
Areas treated: Face (full or specific zones), neck, décolletage, hands, periorbital, perioral
Onset: Skin quality improvement begins building after session 2; full effect assessed at 4–8 weeks after completing the course
Duration: 6–12 months before a maintenance session; varies by patient
Downtime: Minimal. Small bumps (wheals) resolve within hours. Mild redness for 1–4 hours. Most patients return to normal activity the same day.
Pain level: Moderate — multiple intradermal injections sting. Topical anesthetic cream beforehand is standard.
Cost: $250–$600 per session; $800–$2,000 for a complete course
| Factor | PN / PDRN | HA Skin Boosters (Profhilo, Skinboosters) |
|---|---|---|
| Primary mechanism | Biological regeneration | Hydration, scaffolding |
| Effect on collagen | Direct stimulation | Indirect (via hydration) |
| Immediate hydration | Modest | Significant |
| Fine lines | Good over series | Good |
| Skin laxity | Moderate | Moderate |
| Under-eye area | Yes (specific formulations) | Risky (HA can cause swelling) |
| Reversible | No (no hyaluronidase) | Yes (hyaluronidase dissolves HA) |
| Evidence base | Growing | Well-established (especially Profhilo) |
Combination approach: Many aesthetic providers use PN and HA boosters together — in the same session or alternating sessions — for complementary effects. The HA provides the immediate hydration response; the PN drives the longer-term regenerative response.
Good candidates:
Not the right choice for:
Looking for providers offering skin biostimulator treatments? Browse injectable providers on MedSpot →